Document Detail


Closure of perimembranous ventricular septal defects with aneurysmal tissue using the amplazter duct occluder I: Lessons learned and medium term follow up.
MedLine Citation:
PMID:  22907908     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Objectives: The aim of this report is to describe our experience with closure of perimembranous ventricular septal defects (PMVSD) with aneurysm using the Amplatzer Duct Occluder I (ADO I). Background: Atrio-ventricular block (AVB) remains the most troublesome complication of device closure of PMVSDs. Many PMVSDs are associated with an aneurysm that protrudes into the right ventricle. We believe that devices implanted entirely within the VSD aneurysm avoid the risk of AVB. Methods: A retrospective analysis of patients with PMVSD and aneurysm who underwent attempted ADO I device closure between 3/2004 and 8/2010 [Rady Children's Hospital-San Diego (n = 16), Mattel Children's Hospital at UCLA (n = 4), and Straub Hospital in Honolulu (n = 1)]. Results: Twenty-one patients (16 male) with PMVSD and aneurysm underwent cardiac catheterization for the purpose of VSD closure using an ADO I. Nineteen patients had successful ADO I implantation with the following devices: 10/8 (n = 8), 8/6 (n = 7), 6/4 (n = 3) and 12/10 (n = 2). The procedure was aborted in 2 cases due to temporary AVB and ventricular ectopy during catheterization. One patient developed hemolysis due device malposition and had surgical device retrieval and VSD closure. One patient had new trivial tricuspid regurgitation and in 5/19 the tricuspid regurgitation improved post device closure. Transient accelerated junctional rhythm occurred within 24 hr in 4 patients and nonsustained slow ventricular tachycardia occurred in one patient. At latest follow-up (up to 6 years, median 1.9 years) 11/18 had no residual shunt, 4/18 had trivial and 3/18 small residual shunt. No AVB has been observed. Conclusions: Percutaneous closure of PMVSD with aneurysm using the ADO I appears to have acceptable efficacy and risk. Atrio-ventricular block in up to mid-term follow up was not encountered. © 2011 Wiley Periodicals, Inc.
Authors:
Howaida G El Said; Andras Bratincsak; Brent M Gordon; John W Moore
Related Documents :
20606328 - Effect of all-trans-retinoic acid on the development of chronic hypoxia-induced pulmona...
22580988 - Bilateral middle cerebral artery aneurysms: a comparative study of unilateral and bilat...
7805328 - Scintigraphic appearance of albuterol-induced inhibition of hypoxic pulmonary vasoconst...
22830758 - Nonrigid registration-based coronary artery motion correction for cardiac computed tomo...
23641268 - A case of simultaneous endovascular aneurysmal repair (evar) and coronary artery bypass...
17114538 - Segmental arterial mediolysis: cta findings at presentation and follow-up.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-20
Journal Detail:
Title:  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions     Volume:  -     ISSN:  1522-726X     ISO Abbreviation:  Catheter Cardiovasc Interv     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100884139     Medline TA:  Catheter Cardiovasc Interv     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Wiley Periodicals, Inc.
Affiliation:
Division of Pediatric Cardiology, Rady Children's Hospital-San Diego, San Diego, California; Department of Pediatrics, University of California San Diego, School of Medicine, San Diego, California. helsaid@rchsd.org.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Beyond Heparinization: Design of Highly Potent Thrombin Inhibitors Suitable for Surface Coupling.
Next Document:  Preparation of Copper(I) Pseudo-rotaxanes from Bis-phosphine Ligands.